Citadel Advisors’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
|
|||||
|
2025
Q1 | $301K | Sell |
|
|||||
|
2024
Q4 | $1.29M | Sell |
|
|||||
|
2024
Q3 | $5.75M | Buy |
|
|||||
|
2024
Q2 | $105K | Buy |
|
|||||
|
2024
Q1 | $566 | Sell |
|
|||||
|
2023
Q4 | $4.07M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $7.46K | Hold |
|
|||||
|
2023
Q1 | $9.01K | Sell |
|
|||||
|
2022
Q4 | $415K | Buy |
|
|||||
|
2022
Q3 | $97K | Sell |
|
|||||
|
2022
Q2 | $411K | Sell |
|
|||||
|
2022
Q1 | $1.36M | Buy |
|
|||||
|
2021
Q4 | $423K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $949K | Sell |
|
|||||
|
2020
Q3 | $5.49M | Buy |
|